Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ex Vivo Monocyte and Lymphocyte Stimulation Tests and Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva)

NCT00602823 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00602823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00602823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ex Vivo Monocyte and Lymphocyte Stimulation Tests and Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva)
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Completed
Start date
February 28, 2006
Completion date
May 31, 2006
Enrollment
20
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis